Lan, Fan-Yun
Sidossis, Amalia
Iliaki, Eirini
Buley, Jane
Nathan, Neetha
Bruno-Murtha, Lou Ann
Kales, Stefanos N.
Article History
Received: 12 January 2022
Accepted: 26 April 2022
First Online: 12 May 2022
Declarations
:
: The data we used were de-identified. The need for a consent was waived by the Cambridge Health Alliance Institutional Review Board (Protocol number 4/29/202-003). Additionally, the study was exempted by the Cambridge Health Alliance Institutional Review Board (Protocol number 4/29/202-003). We confirm that all methods were carried out in accordance with the Declaration of Helsinki.
: Not applicable.
: S.N.K. has received COVID-19-related consulting fees from Open Health and has owned shares of Regeneron, Moderna and Astra-Zeneca. All other authors declare no competing interests.